Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • State of the Art
  • Published:

State-of-the-Art

Prevention of Group B Streptococcus early-onset disease: a toolkit by the California Perinatal Quality Care Collaborative

Journal of Perinatology volume 30, pages 77–87 (2010)Cite this article

Abstract

The California Perinatal Quality Care Collaborative (CPQCC) was organized in 1996 in an effort to improve perinatal outcomes in California. CPQCC has a robust infrastructure of quality improvement resources and expertise and uses a database of demographic and outcome data from neonatal intensive care units in California. In 2004, CPQCC developed a toolkit to provide an evidence-based framework and supporting documents for hospitals to use in systematically addressing persistent early-onset disease (EOD) because of Group B Streptococcus (GBS) in their centers. The CPQCC toolkit was based on the 2002 Centers for Disease Control guideline, ‘Prevention of Perinatal Group B Streptococcal Disease.’ This article presents an updated version of the CPQCC toolkit reflecting several population studies published since the 2002 guideline. Current epidemiological trends in incidence of EOD with GBS, changes in antibiotic sensitivity and the potential value of newer strategies are discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Abbreviations

CPQCC:

California Perinatal Quality Care Collaborative

PIW:

Problem Identification Worksheet

NICU:

Neonatal Intensive Care Unit

CDC:

Centers for Disease Control

GBS:

Group B Streptococcus

PPV:

Positive Predictive Value

NPV:

Negative Predictive Value

DNA:

Deoxyribonucleic Acid

PCR:

Polymerase Chain Reaction

AAP:

American Academy of Pediatrics

ACOG:

American College of Obstetrics and Gynecology

E Coli:

Escherichia Coli

ROM:

Rupture of Membranes

PROM:

Premature Rupture of Membranes

VLBW:

Very Low Birth Weight

EOS:

Early Onset Sepsis

EOD:

Early-Onset Disease

PMA:

Post Menstrual Age

References

  1. Horbar JD . The Vermont Oxford Network: evidence-based quality improvement for neonatology. Pediatrics 1999; 103 (1 Suppl E): 350–359.

    CAS  PubMed  Google Scholar 

  2. Horbar JD . Birthweight-adjusted mortality rates for assessing the effectiveness of neonatal intensive care. Med Decis Making 1992; 12 (4): 259–264.

    Article  CAS  PubMed  Google Scholar 

  3. Horbar JD . The Vermont-Oxford Neonatal Network: integrating research and clinical practice to improve the quality of medical care. Semin Perinatol 1995; 19 (2): 124–131.

    Article  CAS  PubMed  Google Scholar 

  4. Horbar JD, Plsek PE, Leahy K . NIC/Q 2000: establishing habits for improvement in neonatal intensive care units. Pediatrics 2003; 111 (4 Part 2): e397–e410.

    PubMed  Google Scholar 

  5. Horbar JD, Rogowski J, Plsek PE, Delmore P, Edwards WH, Hocker J et al. Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics 2001; 107 (1): 14–22.

    Article  CAS  PubMed  Google Scholar 

  6. Wirtschafter DD, Powers RJ . Organizing regional perinatal quality improvement: global considerations and local implementation. Neoreviews 2004; 5 (2): e50–e59.

    Article  Google Scholar 

  7. Bisognano MA, Caldwell C . Best practices in quality leadership. Qual Lett Healthc Lead 1995; 7 (6): 16–21.

    CAS  PubMed  Google Scholar 

  8. Finer NN, Powers RJ, Ou CH, Durand D, Wirtschafter D, Gould JB . Prospective evaluation of postnatal steroid administration: a 1-year experience from the California Perinatal Quality Care Collaborative. Pediatrics 2006; 117 (3): 704–713.

    Article  PubMed  Google Scholar 

  9. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A . Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51 (RR-11): 1–22.

    PubMed  Google Scholar 

  10. CDC. Prevention of perinatal group B Streptococcal disease: a public health perspective. MMWR 1996; 45 (RR-7): 1–24.

    Google Scholar 

  11. Luck S, Torny M, d’Agapeyeff K, Pitt A, Heath P, Breathnach A et al. Estimated early-onset group B streptococcal neonatal disease. Lancet 2003; 361 (9373): 1953–1954.

    Article  PubMed  Google Scholar 

  12. Whitney CG, Plikaytis BD, Gozansky WS, Wenger JD, Schuchat A . Prevention practices for perinatal group B streptococcal disease: a multi-state surveillance analysis. Neonatal Group B Streptococcal Disease Study Group. Obstet Gynecol 1997; 89 (1): 28–32.

    Article  CAS  PubMed  Google Scholar 

  13. Centers for Disease Control and Prevention (CDC). Adoption of hospital policies for prevention of perinatal group B streptococcal disease—United States, 1997. MMWR Morb Mortal Wkly Rep 1998; 47 (32): 665–670.

    Google Scholar 

  14. Factor SH, Whitney CG, Zywicki SS, Schuchat A . Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team. Obstet Gynecol 2000; 95 (3): 377–382.

    CAS  PubMed  Google Scholar 

  15. Davis RL, Hasselquist MB, Cardenas V, Zerr DM, Kramer J, Zavitkovsky A et al. Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization. Am J Obstet Gynecol 2001; 184 (4): 603–610.

    Article  CAS  PubMed  Google Scholar 

  16. Adair CE, Kowalsky L, Quon H, Ma D, Stoffman J, McGeer A et al. Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study. CMAJ 2003; 169 (3): 198–203.

    PubMed  PubMed Central  Google Scholar 

  17. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002; 347 (4): 233–239.

    Article  PubMed  Google Scholar 

  18. Rosenstein NE, Schuchat A . Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group. Obstet Gynecol 1997; 90 (6): 901–906.

    Article  CAS  PubMed  Google Scholar 

  19. Centers for Disease Control and Prevention (CDC). Perinatal group B streptococcal disease after universal screening recommendations—United States, 2003 to 2005. MMWR Morb Mortal Wkly Rep 2007; 56 (28): 701–705.

    Google Scholar 

  20. Chen KT, Puopolo KM, Eichenwald EC, Onderdonk AB, Lieberman E . No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. Am J Obstet Gynecol 2005; 192 (4): 1167–1171.

    Article  PubMed  Google Scholar 

  21. Angstetra D, Ferguson J, Giles WB . Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit. Aust N Z J Obstet Gynaecol 2007; 47 (5): 378–382.

    Article  PubMed  Google Scholar 

  22. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP . Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis 1983; 148 (5): 810–816.

    Article  CAS  PubMed  Google Scholar 

  23. Easmon CS, Hastings MJ, Deeley J, Bloxham B, Rivers RP, Marwood R . The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci. Br J Obstet Gynaecol 1983; 90 (7): 633–635.

    Article  CAS  PubMed  Google Scholar 

  24. Matorras R, Garcia-Perea A, Omenaca F, Diez-Enciso M, Madero R, Usandizaga JA . Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur J Obstet Gynecol Reprod Biol 1991; 40 (1): 57–62.

    Article  CAS  PubMed  Google Scholar 

  25. Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP . Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 1983; 148 (5): 802–809.

    Article  CAS  PubMed  Google Scholar 

  26. Puopolo KM, Madoff LC, Eichenwald EC . Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005; 115 (5): 1240–1246.

    Article  PubMed  Google Scholar 

  27. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR . The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996; 88 (5): 811–815.

    Article  CAS  PubMed  Google Scholar 

  28. Edwards RK, Clark P, Sistrom CL, Duff P . Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on Gram-negative pathogens. Obstet Gynecol 2002; 100 (3): 534–539.

    CAS  PubMed  Google Scholar 

  29. Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA . Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis 2004; 39 (8): 1129–1135.

    Article  PubMed  Google Scholar 

  30. Bergseng H, Bevanger L, Rygg M, Bergh K . Real-time PCR targeting the sip gene for detection of group B Streptococcus colonization in pregnant women at delivery. J Med Microbiol 2007; 56 (Part 2): 223–228.

    Article  CAS  PubMed  Google Scholar 

  31. Edwards RK, Novak-Weekley SM, Koty PP, Davis T, Leeds LJ, Jordan JA . Rapid group B streptococci screening using a real-time polymerase chain reaction assay. Obstet Gynecol 2008; 111 (6): 1335–1341.

    Article  PubMed  Google Scholar 

  32. Bergh K, Stoelhaug A, Loeseth K, Bevanger L . Detection of group B streptococci (GBS) in vaginal swabs using real-time PCR with TaqMan probe hybridization. Indian J Med Res 2004; 119 (Suppl): 221–223.

    CAS  PubMed  Google Scholar 

  33. Money D, Dobson S, Cole L, Karacabeyli E, Blondel-Hill E, Milner R et al. An evaluation of a rapid real time polymerase chain reaction assay for detection of group B streptococcus as part of a neonatal group B streptococcus prevention strategy. J Obstet Gynaecol Can 2008; 30 (9): 770–775.

    Article  PubMed  Google Scholar 

  34. Heath PT, Feldman RG . Vaccination against group B streptococcus. Expert Rev Vaccines 2005; 4 (2): 207–218.

    Article  CAS  PubMed  Google Scholar 

  35. Baker CJ, Kasper DL . Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976; 294 (14): 753–756.

    Article  CAS  PubMed  Google Scholar 

  36. Baker CJ, Edwards MS . Group B streptococcal conjugate vaccines. Arch Dis Child 2003; 88 (5): 375–378.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Lin FY, Philips III JB, Azimi PH, Weisman LE, Clark P, Rhoads GG et al. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. J Infect Dis 2001; 184 (8): 1022–1028.

    Article  CAS  PubMed  Google Scholar 

  38. Davies HD, Adair C, McGeer A, Ma D, Robertson S, Mucenski M et al. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis 2001; 184 (3): 285–291.

    Article  CAS  PubMed  Google Scholar 

  39. Lachenauer CS, Kasper DL, Shimada J, Ichiman Y, Ohtsuka H, Kaku M et al. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 1999; 179 (4): 1030–1033.

    Article  CAS  PubMed  Google Scholar 

  40. Hoogkamp-Korstanje JA, Gerards LJ, Cats BP . Maternal carriage and neonatal acquisition of group B streptococci. J Infect Dis 1982; 145 (6): 800–803.

    Article  CAS  PubMed  Google Scholar 

  41. Suara RO, Adegbola RA, Baker CJ, Secka O, Mulholland EK, Greenwood BM . Carriage of group B Streptococci in pregnant Gambian mothers and their infants. J Infect Dis 1994; 170 (5): 1316–1319.

    Article  CAS  PubMed  Google Scholar 

  42. Baker CJ . Vaccine prevention of group B streptococcal disease. Pediatr Ann 1993; 22 (12): 711–714.

    Article  CAS  PubMed  Google Scholar 

  43. Baker CJ, Rench MA, Paoletti LC, Edwards MS . Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults. Vaccine 2007; 25 (1): 55–63.

    Article  CAS  PubMed  Google Scholar 

  44. Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL . Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med 1988; 319 (18): 1180–1185.

    Article  CAS  PubMed  Google Scholar 

  45. Kaplan JE, Masur H, Holmes KK . 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). MMWR Recomm Rep 1999; 48 (RR-10): 1–59, 61–66.

    Google Scholar 

  46. Lieu TA, Mohle-Boetani JC, Ray GT, Ackerson LM, Walton DL . Neonatal group B streptococcal infection in a managed care population. Perinatal Group B Streptococcal Infection Study Group. Obstet Gynecol 1998; 92 (1): 21–27.

    Article  CAS  PubMed  Google Scholar 

  47. Schuchat A, Roome A, Zell ER, Linardos H, Zywicki S, O’Brien KL . Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections. Matern Child Health J 2002; 6 (2): 107–114.

    Article  PubMed  Google Scholar 

  48. Riley L, Appollon K, Haider S, Chan-Flynn S, Cohen A, Ecker J et al. ‘Real World’ compliance with strategies to prevent early-onset group B streptococcal disease. J Perinatol 2003; 23 (4): 272–277.

    Article  PubMed  Google Scholar 

  49. Schuchat A, Oxtoby M, Cochi S, Sikes RK, Hightower A, Plikaytis B et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990; 162 (3): 672–677.

    Article  CAS  PubMed  Google Scholar 

  50. Gavino M, Wang E . A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am J Obstet Gynecol 2007; 197 (4): 388 e1–4.

    Article  PubMed  Google Scholar 

  51. Newton ER . Preterm labor, preterm premature rupture of membranes, and chorioamnionitis. Clin Perinatol 2005; 32 (3): 571–600.

    Article  PubMed  Google Scholar 

  52. Escobar GJ, Li DK, Armstrong MA, Gardner MN, Folck BF, Verdi JE et al. Neonatal sepsis workups in infants 2000 grams at birth: a population-based study. Pediatrics 2000; 106 (2 Part 1): 256–263.

    Article  CAS  PubMed  Google Scholar 

  53. Bland ML, Vermillion ST, Soper DE, Austin M . Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. Am J Obstet Gynecol 2001; 184 (6): 1125–1126.

    Article  CAS  PubMed  Google Scholar 

  54. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S et al. Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999 to 2005. JAMA 2008; 299 (17): 2056–2065.

    Article  CAS  PubMed  Google Scholar 

  55. Joseph TA, Pyati SP, Jacobs N . Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. Arch Pediatr Adolesc Med 1998; 152 (1): 35–40.

    Article  CAS  PubMed  Google Scholar 

  56. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347 (4): 240–247.

    Article  PubMed  Google Scholar 

  57. Moore MR, Schrag SJ, Schuchat A . Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003; 3 (4): 201–213.

    Article  PubMed  Google Scholar 

  58. Baltimore RS, Huie SM, Meek JI, Schuchat A, O’Brien KL . Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001; 108 (5): 1094–1098.

    Article  CAS  PubMed  Google Scholar 

  59. Hyde TB, Hilger TM, Reingold A, Farley MM, O’Brien KL, Schuchat A . Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002; 110 (4): 690–695.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Courtney Nisbet, MS, the CPQCC Quality Improvement Program Manager, for her helpful assistance in the preparation of the toolkit since its inception and along with Megan Sullivan, CPQCC Program Assistant, for their help and technical expertise in the preparation of this article. We also thank Paul Sharek, MD, the CPQCC Director of Quality for his support, many contributions and review of this article.

Author information

Author notes

  1. R J Powers and D Wirtschafter: D Wirtschafter: California Perinatal Quality Improvement Collaborative.

  2. see Appendix.

Authors and Affiliations

  1. California Perinatal Quality Care Collaborative, Palo Alto, CA, USA

    R J Powers & D Wirtschafter

Authors
  1. R J Powers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Wirtschafter
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

and the Perinatal Quality Improvement Panel of the California Perinatal Quality Care Collaborative

Corresponding author

Correspondence to R J Powers.

Additional information

Supplementary Information accompanies the paper on the Journal of Perinatology website (http://www.nature.com/jp)

Supplementary information

Appendix

Appendix

Members of the CPQCC Perinatal Quality Improvement Panel

Paul Sharek, MD, MPH, FAAP; Shabbir Ahmad, DVM, MS, PhD; Richard Bell, MD; D Lisa Bollman, RN, MSN, CPHQ; Carlos Botas, MD; Mary Campbell Bliss, RN, CNS, CLC; Kathy Chance, MD; Margaret Crockett; Marian Dalsey, MD; David J Durand MD; Neil Finer, MD; Allen Fischer, MD; Jeffrey Gould, MD, MPH; Balaji Govindaswami, MD, MPH; Kim Gregory, MD, MPH; Priscilla Joe, MD; Lisa Korst, MD, PhD; Paul Kurtin, MD; Elliott Main, MD; Frank L Mannino, MD; Guadalupe Padilla-Robb, MD; Janet Pettit, RN, MSN, NNP; Asha Puri, MD; Karen Ramstrom, DO; Maynard Rasmussen, MD; Virender Rehan, MD; William Rhine, MD; Charles F Simmons, MD; Leona Shields, RN, MN, NP; Susann J Steinberg, MD, ABPM, Chief; Richard E Topel, MD; Lucy Vanotterloo, RN, MSN; Nadarasa Visveshwara, MD; Paul Wozniak, MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Powers, R., Wirtschafter, D. & and the Perinatal Quality Improvement Panel of the California Perinatal Quality Care Collaborative. Prevention of Group B Streptococcus early-onset disease: a toolkit by the California Perinatal Quality Care Collaborative. J Perinatol 30, 77–87 (2010). https://doi.org/10.1038/jp.2009.95

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2009.95

Keywords

This article is cited by

Search

Advanced search

Quick links